本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

4.63
+0.03000.65%
盘后4.40-0.2300-4.97%19:41 EDT
成交量:59.18万
成交额:269.68万
市值:3.16亿
市盈率:-2.10
高:4.69
开:4.60
低:4.35
收:4.60
数据加载中...
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/29

关联方拟减持公告

144 - Report of proposed sale of securities
2023/03/22

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/10

重要事件披露

8-K - Current report
2023/03/09

重要事件披露

8-K - Current report
2023/03/09

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/16

重要事件披露

8-K - Current report
2022/11/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/23

重要事件披露

8-K - Current report